Markets declined over the week, slipping more than one percent, mainly due to ongoing uncertainty over global tariffs and a ...

New Delhi, In an event-heavy week, stock investors will track quarterly earnings of several bluechip firms, the likely ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.